EGFR, MMP9, and MUC4 expression levels were assessed in FFPE tissue biopsies from 60 glioma patients (20 grade II, 20 grade III, and 20 GBM patients, following the 2016 WHO classification). Here, MMP9 is linked to glioblastoma.